Roche's Q1 COVID-19 tests business saves the day for slumping drug division – Reuters

Roche’s Q1 COVID-19 tests business saves the day for slumping drug division – Reuters

Swiss drugmaker Roche (ROG.S) on Wednesday stuck to its 2021 forecast for revenue growth, as first-quarter sales of COVID-19 tests offset a slumping main drug business that has been hurt as the pandemic limits doctor visits for other diseases.

Read More…

You May Also Like